Clinical trial
Double-blind Placebo Controlled Trial of the Treatment of Chronic Laryngitis With Amitryptiline
NCT02434523 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blind Placebo Controlled Trial of the Treatment of Chronic Laryngitis With Amitryptiline
- Lead sponsor
- Boston Medical Center
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- September 30, 2013
- Completion date
- January 31, 2015
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic laryngeal neuropathy, laryngeal diseases